Abstract
Results There were 161 cases comprising NHL, 42 (25.5%); HL, 15 (9.3%), and BL, 104, (64.6%). Seven (4.3%), aged 2-49 (median = 41) years were retroviral positive. Of these, 4 (3 males, 1 female, aged 28-49 (median = 38.5) years) had NHL, 2 (both females) HL, and 1 case, a 2-year-old boy with HIV since birth, had Burkitt’s and an HIVpositive mother. All, except one female with stage 1 HL, presented late (at least clinical stage IIIb). Three patients with NHL and 1 with late-stage HL succumbed to their disease within 1-3 weeks of hospital admission. The remaining 3 patients had been responding satisfactorily to chemotherapy (CHOP for NHL, ABVD for HL, and COM for Burkitt’s lymphoma.)
Highlights
Open AccessL Salawu1*, RA Bolarinwa, OO Lawal, AA Oyekunle, O Adeodu, EA Adejuyigbe, KA Adelusola, NO Akinola, MA Ndakotsu, MA Durosinmi
In comparison to the western world, aggressive nonHodgkin’s lymphoma (NHL) including primary central nervous system (CNS) lymphoma, as AIDS-defining disease, is less common in sub-Saharan Africa even with its high HIV/AIDS prevalence
We studied the occurrence of HIV/AIDS-related lymphomas in Nigerian patients with a view toward highlighting the incidence
Summary
L Salawu1*, RA Bolarinwa, OO Lawal, AA Oyekunle, O Adeodu, EA Adejuyigbe, KA Adelusola, NO Akinola, MA Ndakotsu, MA Durosinmi. From 12th International Conference on Malignancies in AIDS and Other Acquired Immunodeficiencies (ICMAOI) Bethesda, MD, USA. From 12th International Conference on Malignancies in AIDS and Other Acquired Immunodeficiencies (ICMAOI) Bethesda, MD, USA. 26-27 April, 2010
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have